Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,224,023
-$290,352 QoQ
Shares Held
146,065
-19.9% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. EBS ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in EBS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,224,023 | 146,065 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,514,375 | 182,455 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,546,183 | 206,002 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,354,069 | 380,280 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,606,447 | 565,274 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,635,080 | 747,959 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $14,721,510 | 1,539,907 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,522,615 | 900,912 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,117,335 | 896,970 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,258,983 | 892,879 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $700,502 | 291,876 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,030,148 | 302,985 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,805,433 | 789,855 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,943,569 | 863,279 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,115,367 | 2,126,619 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,592,762 | 981,075 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,471,391 | 820,599 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $36,435,081 | 887,362 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,046,685 | 990,262 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,466,328 | 728,307 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $47,483,684 | 753,829 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $97,257,348 | 1,046,791 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $96,326,627 | 1,075,074 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $68,148,922 | 659,527 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $63,425,085 | 802,037 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $52,781,279 | 912,224 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||